AU2005333518B2 - Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators - Google Patents

Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators Download PDF

Info

Publication number
AU2005333518B2
AU2005333518B2 AU2005333518A AU2005333518A AU2005333518B2 AU 2005333518 B2 AU2005333518 B2 AU 2005333518B2 AU 2005333518 A AU2005333518 A AU 2005333518A AU 2005333518 A AU2005333518 A AU 2005333518A AU 2005333518 B2 AU2005333518 B2 AU 2005333518B2
Authority
AU
Australia
Prior art keywords
methyl
pyrrole
hexahydroindeno
mmol
observed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005333518A
Other languages
English (en)
Other versions
AU2005333518A1 (en
AU2005333518A8 (en
Inventor
Youssef L. Bennani
Bayard Huck
Michael J. Robarge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Athersys Inc
Original Assignee
Athersys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athersys Inc filed Critical Athersys Inc
Publication of AU2005333518A1 publication Critical patent/AU2005333518A1/en
Publication of AU2005333518A8 publication Critical patent/AU2005333518A8/en
Application granted granted Critical
Publication of AU2005333518B2 publication Critical patent/AU2005333518B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2005333518A 2004-07-29 2005-07-26 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators Ceased AU2005333518B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59204704P 2004-07-29 2004-07-29
US60/592,047 2004-07-29
PCT/US2005/026415 WO2007081299A2 (en) 2004-07-29 2005-07-26 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators

Publications (3)

Publication Number Publication Date
AU2005333518A1 AU2005333518A1 (en) 2007-02-22
AU2005333518A8 AU2005333518A8 (en) 2008-08-07
AU2005333518B2 true AU2005333518B2 (en) 2010-12-02

Family

ID=37075566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005333518A Ceased AU2005333518B2 (en) 2004-07-29 2005-07-26 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators

Country Status (16)

Country Link
US (5) US20060025601A1 (enExample)
EP (1) EP1841738A4 (enExample)
JP (1) JP4990164B2 (enExample)
KR (2) KR20130047765A (enExample)
CN (1) CN101516372A (enExample)
AR (1) AR050274A1 (enExample)
AU (1) AU2005333518B2 (enExample)
BR (1) BRPI0512869A (enExample)
CA (1) CA2603249C (enExample)
IL (1) IL180977A (enExample)
NO (1) NO20071102L (enExample)
NZ (1) NZ552806A (enExample)
RU (1) RU2007107494A (enExample)
TW (1) TWI377195B (enExample)
WO (1) WO2007081299A2 (enExample)
ZA (1) ZA200700684B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025601A1 (en) 2004-07-29 2006-02-02 Athersys, Inc. Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
JP4866901B2 (ja) 2007-02-07 2012-02-01 協和発酵キリン株式会社 ３環系化合物
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
WO2009097995A1 (de) * 2008-02-07 2009-08-13 Sanofi-Aventis Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP3081213B1 (en) 2008-08-06 2020-04-01 Kyowa Kirin Co., Ltd. Tricyclic compound
TW201041851A (en) 2009-03-10 2010-12-01 Organon Nv Tricyclic heterocyclic derivatives
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CN106380440B (zh) * 2016-08-30 2019-02-01 华东师范大学 一种茚酮并吡咯类衍生物及其合成方法和应用
CN106631989B (zh) * 2016-11-26 2019-07-16 威海迪素制药有限公司 一种盐酸多奈哌齐有关物质e的制备方法
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170093A1 (en) * 1984-07-25 1986-02-05 Abbott Laboratories 1,2,3,3a,8,8a-Hexahydro-Indeno-(1,2-c)Pyrrdes
US4622405A (en) * 1984-07-25 1986-11-11 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
WO1990006927A1 (en) * 1988-12-15 1990-06-28 Abbott Laboratories 5-ht selective agents
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
US5244888A (en) * 1989-11-17 1993-09-14 Abbott Laboratories 5-HT selective agents
US5646173A (en) * 1993-10-22 1997-07-08 Hoffmann-La Roche Inc. Tricyclic pyrrole derivatives useful as 5-HT selective agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351711B2 (en) * 2003-07-31 2008-04-01 Janssen Pharmaceutical, N.V. Tricyclic indanyls as integrin inhibitors
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
US20060025601A1 (en) * 2004-07-29 2006-02-02 Athersys, Inc. Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170093A1 (en) * 1984-07-25 1986-02-05 Abbott Laboratories 1,2,3,3a,8,8a-Hexahydro-Indeno-(1,2-c)Pyrrdes
US4622405A (en) * 1984-07-25 1986-11-11 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
WO1990006927A1 (en) * 1988-12-15 1990-06-28 Abbott Laboratories 5-ht selective agents
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
US5244888A (en) * 1989-11-17 1993-09-14 Abbott Laboratories 5-HT selective agents
US5646173A (en) * 1993-10-22 1997-07-08 Hoffmann-La Roche Inc. Tricyclic pyrrole derivatives useful as 5-HT selective agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
D6: LAHIRI S C ET AL., JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 57, no. 6, 1 June 1968, pages 1013-1016, XP002056178, ISSN: 0022-3549 *
D7: LUCID K ET AL., HETEROCYCLES, vol. 62, 7 November 2003, pages 543-557, XP002305186, ISSN: 0385-5414 *

Also Published As

Publication number Publication date
NO20071102L (no) 2007-04-20
KR20080025657A (ko) 2008-03-21
US20090239925A1 (en) 2009-09-24
AR050274A1 (es) 2006-10-11
TW200619196A (en) 2006-06-16
CN101516372A (zh) 2009-08-26
AU2005333518A1 (en) 2007-02-22
US8716324B2 (en) 2014-05-06
EP1841738A4 (en) 2010-06-02
KR101257233B1 (ko) 2013-04-29
TWI377195B (en) 2012-11-21
US7935830B2 (en) 2011-05-03
US20110172283A1 (en) 2011-07-14
KR20130047765A (ko) 2013-05-08
BRPI0512869A (pt) 2008-04-08
ZA200700684B (en) 2008-10-29
WO2007081299A3 (en) 2007-09-20
NZ552806A (en) 2009-09-25
JP4990164B2 (ja) 2012-08-01
US20060025601A1 (en) 2006-02-02
IL180977A (en) 2012-08-30
US20140206739A1 (en) 2014-07-24
RU2007107494A (ru) 2008-09-10
CA2603249A1 (en) 2007-07-19
JP2008508365A (ja) 2008-03-21
US20120252859A1 (en) 2012-10-04
US8232311B2 (en) 2012-07-31
CA2603249C (en) 2014-01-21
US9096520B2 (en) 2015-08-04
EP1841738A2 (en) 2007-10-10
WO2007081299A2 (en) 2007-07-19
AU2005333518A8 (en) 2008-08-07
IL180977A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
US9096520B2 (en) Tricyclic ideno-pyrrole derivatives as serotonin receptor modulators
US8716276B2 (en) Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof
US20100190772A1 (en) Substituted Azepine Derivatives As Serotonin Receptor Modulators
KR101721025B1 (ko) 테트라하이드로벤조티오펜 화합물
US20090069365A1 (en) Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
DE60026581T2 (de) Indolderivate zur behandlung von depression und angstzuständen
MX2007001061A (en) Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
GB2306471A (en) Methanesulfonate salts of antipsychotic benzofuran derivatives

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND PRIORITY DETAILS FROM 60/592,047 29 JUN 2004 US TO 60/592,047 29 JUL 2004 US

TH Corrigenda

Free format text: IN VOL 21, NO 8, PAGE(S) 850 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE -NAME INDEX UNDER THE NAME ATHERSYS, INC., APPLICATION NO. 2005333518, UNDER INID(43), CORRECT THE DATE TO READ 19.07.07

Free format text: IN VOL 21, NO 8, PAGE(S) 831 UNDER THE HEADING APPLICATIONS OPI NAME INDEX UNDER THE NAME ATHERSYS, INC., APPLICATION NO. 2005333518, UNDER INID(43), CORRECT THE DATE TO READ 19.07.07

TH Corrigenda

Free format text: IN VOL 21, NO 8, PAGE(S) 850 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE -NAME INDEX UNDER THE NAME ATHERSYS, INC., APPLICATION NO. 2005333518, UNDER INID(43), CORRECT THE DATE TO READ 19.07.07

Free format text: IN VOL 21, NO 8, PAGE(S) 831 UNDER THE HEADING APPLICATIONS OPI NAME INDEX UNDER THE NAME ATHERSYS, INC., APPLICATION NO. 2005333518, UNDER INID(43), CORRECT THE DATE TO READ 19.07.07

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired